Physician profile
Lori H Cavender
NPI 1285955419
$2,489.47
in general payments reported to CMS, 2019-2025
38 companies · $513 in 2025
The $513 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $80.50 · 2021: $46.44 · 2022: $387 · 2023: $509 · 2024: $405 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $380.79 | 2019-2025 | Veozah |
| Abbvie INC. | $210.41 | 2019-2023 | Lo Loestrin Fe |
| Evofem Biosciences, INC. | $197.52 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $120.48 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $116.01 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $113.90 | 2019-2025 | |
| Pfizer INC. | $107.53 | 2019-2022 | |
| Coopersurgical, INC. | $93.08 | 2019-2024 | Paragard T 380a |
| Exeltis, USA INC. | $90.36 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $90.27 | 2019-2022 | |
| Baxter Healthcare | $82.40 | 2023-2024 | Tisseel, Perclot |
| Lupin INC. | $80.85 | 2019-2020 | |
| Shield Therapeutics INC | $75.70 | 2023 | Accrufer |
| Myovant Sciences INC. | $68.95 | 2022 | |
| Medtronic, INC. | $67.46 | 2025 | Signia |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $57.65 | 2022-2024 | |
| Octapharma USA, INC. | $39.76 | 2025 | Fibryga |
| Daiichi Sankyo INC. | $38.41 | 2019 | |
| Avion Pharmaceuticals | $37.29 | 2019-2023 | Balcoltra |
| Aspira Women'S Health INC | $36.79 | 2020-2024 | Ova1 |
| Duchesnay USA Incorporated | $33.88 | 2019 | |
| Meditrina | $31.35 | 2022-2024 | |
| Amag Pharmaceuticals, INC. | $31.01 | 2019 | |
| Bluewind Medical | $29.14 | 2025 | Revi |
| Pacira Pharmaceuticals Incorporated | $28.21 | 2023 | Exparel |
| Biogen, INC. | $26.19 | 2025 | Zurzuvae |
| Mimedx Group, INC. | $22.64 | 2024 | |
| Minerva Surgical, INC | $22.40 | 2019 | |
| Dexcom, INC. | $21.38 | 2025 | Dexcom G6 Transmitter |
| Mylan Pharmaceuticals INC. | $20.02 | 2022 | |
| Dilon Technologies, INC. | $19.69 | 2025 | Hemoblast Bellows |
| Boston Scientific Corporation | $18.86 | 2025 | Axonics |
| Exact Sciences Corporation | $16.30 | 2023 | Cologuard Collection Kit |
| Millicent US INC | $15.23 | 2024 | Intrarosa, Femring |
| Olympus America INC. | $13.68 | 2019 | |
| Molnlycke Health Care US, LLC | $11.78 | 2019 | |
| Allergan, INC. | $11.05 | 2019 | |
| Renovia INC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Cavender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.